NDC 55154-2139-00 - Oxcarbazepine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-2139
- Requested NDC
- 55154-2139-00
- Package NDCs from labels
- 55154-2139-0, 55154-2139-00
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-07-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxcarbazepine - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-07-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-2139-0 | Oxcarbazepine | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 5 | |
| 55154-2139-0 | Oxcarbazepine | 10 in 1 BAG | TABLET, FILM COATED | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-2139 | OXCARBAZEPINE TABLET, FILM COATED [CARDINAL HEALTH 107, LLC] | 3 | Current NDC, 2 package rows | 20240929_3e0f8d9f-7659-4524-8f93-6200314356c8.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD. | 30468afc-9616-4765-b046-12e97a0a7827 | 2010-12-20 | Warnings | 15FIX9V2JP |
| Oxcarbazepine | OXCARBAZEPINE | Kanchan Healthcare Inc | 7be73d22-f87b-4459-a91c-37c1e34db230 | Warnings, Adverse reactions | VZI5B1W380 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.